Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04163107 · COMPLETED
Trial details
- NCT number
- NCT04163107
- Sponsor
- Norwegian University of Science and Technology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2021-12-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.